NovoCure Ltd Sustainability Reports
NovoCure Limited is an oncology company engaged in the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices for the treatment of solid tumor cancers.
Sector: Manufacturing
Country: Switzerland
Exchange: Nasdaq
LEI: 213800YPP55UMHWA4826
FIGI: BBG009XW8QY0
7 reports from 2015 to 2025
